Results for this period
First quarter1 March 2026–31 May 2026ConsolidatedJapanese GAAPThe width of the band at each stage is based on revenue. The narrower it becomes toward the bottom, the smaller the proportion of revenue that remains as profit. The dotted outline is the full-year forecast and the band inside it is the result for this period. The progress rate is the result divided by the forecast.
塗りつぶした部分が自己資本比率です。総資産のうち、返済のいらない自前の資金がどれだけかを表します。The thin vertical line indicates the level at the end of the previous fiscal year.
Net sales remained solid, led by the Semiconductor Business, and sales in that business significantly exceeded forecasts against the backdrop of a strong semiconductor market. While the sales mix shifted toward higher-margin products, some shipments in the Healthcare Business and deliveries of certain materials for the New Business were delayed, resulting in some scheduled sales being pushed back to the second quarter.
No applicable matters
| Item | Details |
|---|---|
| Fiscal Period Classification | First quarter |
| Accounting standards | Japanese GAAP |
| Consolidated / non-consolidated | Consolidated |
| Period Covered | 1 March 2026–31 May 2026 |
| Net Sales | ¥2,192 million (YoY +22.6%) |
| Operating profit | ¥199 million |
| Ordinary income | ¥145 million |
| Profit attributable to owners of the parent | ¥70 million |
| Net income per share | ¥6.07 |
| Equity ratio | End of the current fiscal period 32.9 / End of previous period 31.8 |
| Total assets | ¥14,520 million |
| Net assets | ¥4,782 million |
| Full-year earnings forecast | Net Sales ¥9,828 million (YoY -2.1%) / Operating profit ¥933 million (YoY +71.9%) / Ordinary income ¥788 million (YoY +16.9%) / Profit attributable to owners of the parent ¥597 million |
| Revision to Earnings Forecast | No revision |
| Annual Dividend Forecast | ¥0 → ¥0 |
| Depreciation and amortization | ¥163,649 thousand |
| Breakdown of extraordinary income (loss) | Extraordinary income Gain on sale of non-current assets ¥13,269 thousand / Extraordinary loss None |
| Disclosure regarding the going concern assumption | No applicable matters |
| Change in accounting policy | Changes due to revisions to standards No / Other changes No / Change in accounting estimate No / Restatement No |
| Changes in the scope of consolidation | Added: 0 companies; excluded: 0 companies |
| Availability of Supplementary Financial Results Materials | Yes |
| Availability of Financial Results Briefing | Available (participants not specified) |
| Issued Shares at Period-End | 11,598,113 |
| Treasury Shares at Period-End | 2,016 |
| Factors Behind Changes in Business Performance | Net sales remained solid, led by the Semiconductor Business, and sales in that business significantly exceeded forecasts against the backdrop of a strong semiconductor market. While the sales mix shifted toward higher-margin products, some shipments in the Healthcare Business and deliveries of certain materials for the New Business were delayed, resulting in some scheduled sales being pushed back to the second quarter. |
Items this document does not state (13)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.Net sales in the Semiconductor Business significantly exceeded forecasts against the backdrop of a strong semiconductor market, and the sales mix shifted toward higher-margin products. Meanwhile, some shipments in the Healthcare Business and deliveries of certain materials for the New Business were delayed, resulting in some scheduled sales being pushed back to the second quarter.